‘A Quiet Place’ Prequel Box Office Speaks Volumes as Costner’s Western Gets a Bumpy Start

 (L-R) Actors Alex Wolff, Djimon Hounsou, Lupita Nyong'o, and Joseph Quinn and attend the New York premiere of Paramount's "A Quiet Place: Day One" at AMC Lincoln Square Theater in New York on June 26, 2024. (AFP)
(L-R) Actors Alex Wolff, Djimon Hounsou, Lupita Nyong'o, and Joseph Quinn and attend the New York premiere of Paramount's "A Quiet Place: Day One" at AMC Lincoln Square Theater in New York on June 26, 2024. (AFP)
TT

‘A Quiet Place’ Prequel Box Office Speaks Volumes as Costner’s Western Gets a Bumpy Start

 (L-R) Actors Alex Wolff, Djimon Hounsou, Lupita Nyong'o, and Joseph Quinn and attend the New York premiere of Paramount's "A Quiet Place: Day One" at AMC Lincoln Square Theater in New York on June 26, 2024. (AFP)
(L-R) Actors Alex Wolff, Djimon Hounsou, Lupita Nyong'o, and Joseph Quinn and attend the New York premiere of Paramount's "A Quiet Place: Day One" at AMC Lincoln Square Theater in New York on June 26, 2024. (AFP)

“A Quiet Place: Day One” is making noise at the box office. The prequel earned an estimated $53 million in its first weekend in North American theaters, according to studio estimates Sunday.

It’s both a franchise best and significantly more than expected. Going into the weekend, prerelease tracking had “Day One” pegged for a $40 million debut, but audiences were clearly more enthusiastic to see the action-horror starring Lupita Nyong’o and Joseph Quinn and released by Paramount. The same could not be said for Kevin Costner’s “Horizon: An American Saga—Chapter 1,” which opened to $11 million.

The “Quiet Place” victory wasn’t quite enough to snag the coveted first place spot on the charts, though. That honor again went to Disney and Pixar’s juggernaut “Inside Out 2,” which added an estimated $57.4 million in its third weekend in theaters, and crossed $1 billion globally.

There’s a distant possibility that the places will shift when actuals are released Monday. But either way it’s good news for movie theaters in a summer season that’s finally heating up but still running far behind last year (down 19%) and pre-pandemic norms (down 36% from 2019).

“Inside Out 2” continues to be a box office phenomenon, the likes of which the industry hasn’t seen since “Barbie” almost a year ago. In just three weeks of release, it’s earned nearly $470 million in North America and $545.5 million internationally, bringing its global total to $1.01 billion. The sequel is the only 2024 release to cross the billion dollar mark and it did it in just 19 days, a record for an animated film.

“A Quiet Place: Day One,” directed by Michael Sarnoski and rated PG-13, is also fast approaching an important threshold out of the gates. Including the $45.5 million from international showings in 59 markets, the $67 million production has already made $98.5 million.

In a rare feat for a third film, it opened higher than both “A Quiet Place” ($50.2 million opening in April 2018) and “A Quiet Place: Part II” ($47.5 million opening in May 2021). John Krasinski, who wrote and directed the first two, continued serving as a producer.

Playing on 3,708 screens in the US and Canada, nearly 40% of its domestic earnings came from “premium screens” including IMAX and other large formats. It entered the marketplace with mostly positive reviews (84% on Rotten Tomatoes); Audiences gave it a B+ CinemaScore and four out of five stars on PostTrak.

The start for “Horizon,” meanwhile, was sluggish. Though older audiences, the ones most likely to support a Western epic, don’t typically rush out to see films on opening weekend the way people often do for horrors and superheroes, the road ahead will not be easy: Reviews have not been great and it got an underwhelming B- CinemaScore.

The stakes are also a little different for “Horizon,” a $100 million production that Costner financed on his own and partnered with Warner Bros. to distribute. It opened in 3,334 locations. A decades-old passion project, he mortgaged property in Santa Barbara, Calif. to finance it and exited “Yellowstone” to see it through. In a bold, unconventional strategy, “Part 2” arrives in theaters later this summer, on Aug. 16. He also has plans for two more movies.



Doctor Charged in Connection with Matthew Perry’s Death Is Expected to Plead Guilty

Matthew Perry appears at the GQ Men of the Year Party in West Hollywood, Calif., on Nov. 17, 2022. (AP)
Matthew Perry appears at the GQ Men of the Year Party in West Hollywood, Calif., on Nov. 17, 2022. (AP)
TT

Doctor Charged in Connection with Matthew Perry’s Death Is Expected to Plead Guilty

Matthew Perry appears at the GQ Men of the Year Party in West Hollywood, Calif., on Nov. 17, 2022. (AP)
Matthew Perry appears at the GQ Men of the Year Party in West Hollywood, Calif., on Nov. 17, 2022. (AP)

One of two doctors charged in the investigation of the death of Matthew Perry is expected to plead guilty Wednesday in a federal court in Los Angeles to conspiring to distribute the surgical anesthetic ketamine.

Dr. Mark Chavez, 54, of San Diego, signed a plea agreement with prosecutors in August and would be the third person to plead guilty in the aftermath of the “Friends” star’s fatal overdose last year.

Prosecutors offered lesser charges to Chavez and two others in exchange for their cooperation as they go after two targets they deem more responsible for the overdose death: another doctor and an alleged dealer that they say was known as “ketamine queen” of Los Angeles.

Chavez is free on bond after turning over his passport and surrendering his medical license, among other conditions.

His lawyer Matthew Binninger said after Chavez’s first court appearance on Aug. 30 that he is “incredibly remorseful” and is “trying to do everything in his power to right the wrong that happened here.”

Also working with federal prosecutors are Perry’s assistant, who admitted to helping him obtain and inject ketamine, and a Perry acquaintance, who admitted to acting as a drug messenger and middleman.

The three are helping prosecutors in their prosecution of Dr. Salvador Plasencia, charged with illegally selling ketamine to Perry in the month before his death, and Jasveen Sangha, a woman who authorities say sold the actor the lethal dose of ketamine. Both have pleaded not guilty and are awaiting trial.

Chavez admitted in his plea agreement that he obtained ketamine from his former clinic and from a wholesale distributor where he submitted a fraudulent prescription.

After a guilty plea, he could get up to 10 years in prison when he is sentenced.

Perry was found dead by his assistant on Oct. 28. The medical examiner ruled ketamine was the primary cause of death. The actor had been using the drug through his regular doctor in a legal but off-label treatment for depression that has become increasingly common.

Perry began seeking more ketamine than his doctor would give him. About a month before the actor’s death, he found Plasencia, who in turn asked Chavez to obtain the drug for him.

“I wonder how much this moron will pay,” Plasencia texted Chavez. The two met up the same day in Costa Mesa, halfway between Los Angeles and San Diego, and exchanged at least four vials of ketamine.

After selling the drugs to Perry for $4,500, Plasencia asked Chavez if he could keep supplying them so they could become Perry’s “go-to.”

Perry struggled with addiction for years, dating back to his time on “Friends,” when he became one of the biggest stars of his generation as Chandler Bing. He starred alongside Jennifer Aniston, Courteney Cox, Lisa Kudrow, Matt LeBlanc and David Schwimmer for 10 seasons from 1994 to 2004 on NBC’s megahit sitcom.